See more : FusionPharm, Inc. (FSPM) Income Statement Analysis – Financial Results
Complete financial analysis of Apollo Medical Holdings, Inc. (AMEH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apollo Medical Holdings, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Brookfield Business Corporation (BBUC.TO) Income Statement Analysis – Financial Results
- ERYTECH Pharma S.A. (ERYP.PA) Income Statement Analysis – Financial Results
- Martello Technologies Group Inc. (DRKOF) Income Statement Analysis – Financial Results
- Jura Energy Corporation (JECFF) Income Statement Analysis – Financial Results
- Northern Genesis Acquisition Corp. III (NGC) Income Statement Analysis – Financial Results
Apollo Medical Holdings, Inc. (AMEH)
About Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.14B | 773.92M | 370.25M | 560.62M | 519.91M | 356.36M | 57.43M | 44.05M | 32.99M | 10.48M | 7.78M | 5.11M | 3.90M | 2.44M | 1.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 944.69M | 596.14M | 348.54M | 467.81M | 361.13M | 273.45M | 48.74M | 34.00M | 22.07M | 9.08M | 6.32M | 4.13M | 3.31M | 1.81M | 1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 199.48M | 177.77M | 21.71M | 92.81M | 158.78M | 82.90M | 8.69M | 10.05M | 10.92M | 1.41M | 1.46M | 978.41K | 581.86K | 627.51K | 11.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 17.43% | 22.97% | 5.86% | 16.56% | 30.54% | 23.26% | 15.14% | 22.81% | 33.11% | 13.43% | 18.77% | 19.14% | 14.93% | 25.70% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Other Expenses | 3.94M | -3.75M | 7.69M | 3.03M | 1.62M | 168.10K | 14.70K | 239.06K | 3.03K | 49.70K | -37.25K | 2.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 95.21M | 79.59M | 15.62M | 58.40M | 66.55M | 45.32M | 19.23M | 17.31M | 11.62M | 5.32M | 3.54M | 1.39M | 577.85K | 730.02K | 847.07K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Cost & Expenses | 1.04B | 675.74M | 364.16M | 526.20M | 427.68M | 318.78M | 67.96M | 51.31M | 33.68M | 14.39M | 9.85M | 5.52M | 3.89M | 2.54M | 1.89M | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Interest Income | 1.98M | 1.57M | 405.00K | 2.02M | 1.26M | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.92M | 5.39M | 2.53M | 4.73M | 561.00K | 79.69K | 82.91K | 542.30K | 1.33M | 679.18K | 930.18K | 304.03K | 126.43K | 53.13K | 55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 29.09M | 11.03M | 25.93M | 18.43M | 19.30M | 19.08M | 351.40K | 351.40K | 334.43K | 31.36K | 20.92K | 12.59K | 11.20K | 35.70K | 19.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 133.35M | 111.40M | 40.27M | 50.85M | 106.29M | 56.72M | -9.88M | -6.68M | -356.87K | -3.83M | -2.09M | -397.90K | 15.21K | -66.81K | -816.04K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| EBITDA Ratio | 11.65% | 14.39% | 10.88% | 9.07% | 20.44% | 15.92% | -17.20% | -15.16% | -1.08% | -36.52% | -26.94% | -7.79% | 0.39% | -2.74% | -77.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 104.27M | 98.18M | 6.09M | 32.42M | 88.43M | 35.15M | -10.54M | -7.27M | -694.33K | -3.91M | -2.08M | -413.34K | 4.02K | -102.52K | -835.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Operating Income Ratio | 9.11% | 12.69% | 1.64% | 5.78% | 17.01% | 9.86% | -18.35% | -16.50% | -2.10% | -37.29% | -26.73% | -8.09% | 0.10% | -4.20% | -79.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -17.65M | -20.43M | 2.78M | -8.57M | -9.60M | 14.57M | 1.81M | -978.30K | -489.83K | -629.48K | -6.82M | -301.19K | -158.75K | -92.77K | -55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 86.62M | 77.75M | 8.87M | 25.84M | 82.63M | 49.71M | -8.73M | -8.24M | -1.18M | -4.54M | -8.90M | -714.53K | -154.73K | -195.28K | -891.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 7.57% | 10.05% | 2.40% | 4.61% | 15.89% | 13.95% | -15.20% | -18.72% | -3.59% | -43.30% | -114.45% | -13.98% | -3.97% | -8.00% | -84.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 40.88M | 31.69M | 9.18M | 8.17M | 22.36M | 3.89M | -47.50K | -71.04K | 163.79K | 19.51K | 4.80K | 5.82K | 1.60K | 800.00 | 800.00 | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Net Income | 45.17M | 68.92M | -23.75M | 14.12M | 10.84M | 25.80M | -8.97M | -9.34M | -1.80M | -5.02M | -8.90M | -720.35K | -156.33K | -196.08K | -891.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Net Income Ratio | 3.95% | 8.91% | -6.42% | 2.52% | 2.08% | 7.24% | -15.62% | -21.21% | -5.46% | -47.88% | -114.51% | -14.09% | -4.01% | -8.03% | -84.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 1.00 | 1.57 | -0.65 | 0.41 | 0.33 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| EPS Diluted | 0.99 | 1.52 | -0.63 | 0.39 | 0.29 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| Weighted Avg Shares Out | 44.97M | 43.83M | 36.53M | 34.71M | 32.89M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
| Weighted Avg Shares Out (Dil) | 45.60M | 43.83M | 37.45M | 36.40M | 37.91M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
7 Healthcare Stocks to Buy for Changing Demographics
These seven healthcare stocks are in a good position to take off as baby boomers continue to age into retirement. The post 7 Healthcare Stocks to Buy for Changing Demographics appeared first on InvestorPlace.
Apollo Medical Holdings, Inc. Announces Purchase of Controlling Interests in Sun Clinical Laboratories
ALHAMBRA, Calif., June 2, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on value-based care, today announced that the Company has...
Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences
ALHAMBRA, Calif., May 11, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced that Brandon Sim, Chief Operating Officer and Chief...
Apollo Medical Holdings, Inc.'s (AMEH) CEO Kenneth Sim on Q1 2021 Results - Earnings Call Transcript
Apollo Medical Holdings, Inc.'s (AMEH) CEO Kenneth Sim on Q1 2021 Results - Earnings Call Transcript
5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
Apollo Medical Holdings, Inc. Schedules 2021 First Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif., April 21, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced that it will release financial results for...
5 MedTech Outperformers With Nearly 40% or More Gain in 2021
Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.
Is Apollo Medical Holdings, Inc. (AMEH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Apollo Medical Holdings, Inc. (AMEH) CEO Kenneth Sim on Q4 2020 Results - Earnings Call Transcript
Apollo Medical Holdings, Inc. (AMEH) CEO Kenneth Sim on Q4 2020 Results - Earnings Call Transcript
Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2020 Results, Highlighted by Record Revenue and Net Income Growth for 2020 and Annual Guidance Beat
ALHAMBRA, Calif., March 10, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced its consolidated financial results for the fourth quarter...
Source: https://incomestatements.info
Category: Stock Reports